This acquisition further expands Ceva's footprint in North America. Centaur's broad range of products, including nutraceuticals, joint therapies and infection-control products, along with an experienced staff will provide Ceva with an excellent base for its expansion in the Canadian market.

Craig Wallace, North America Zone Director for Ceva, said: "The move helps in marketing and distributing current Ceva products and will serve as a strong foundation for future product launches."

Marc Prikazsky, CEO of Ceva Santé Animale, said: "Canada is an important world economy where we needed to have a direct presence. Integrating the two companies will lead to an expansion of networks for both teams, and continues Ceva's growth into new markets."

Dr Charles Povey purchased John E. Slinger Ltd. in 1983. In 1992, he changed the name of the company to Centaur Pharmaceuticals and continued to develop the business into its current success. Dr Greg Hawkins is president of the Guelph, Ontario company, which markets pharmaceuticals, topicals, supplements, diagnostic kits, I.V. sets and nutritional support, and is committed to providing veterinarians across Canada with high quality products and excellence in customer service.